Cytrellis Biosystems, Inc. FDA Recalls

2 recalls on file across devices, 0 of them Class I and 1 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
ellacor System with Micro-Coring Technology-Indicated for use by medical professionals for the treatment of moderate andClass IIJun 23, 2023Potential failure of a bearing adhesive joint that can occur	Potential failure of a bearing adhesive joint that can occur due to an assembly issue of the X/Y stage of the	Class IIDevices	Jun 23, 2023
Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System intended for the treatment of moClass IIApr 7, 2023Irregular core patterns could cause potential overlap of cor	Irregular core patterns could cause potential overlap of cores at the 8% setting, potentially leading to prolo	Class IIDevices	Apr 7, 2023